Frankfurt - Delayed Quote EUR
IGM Biosciences, Inc. (1K0.F)
1.0300
+0.0300
+(3.00%)
At close: May 16 at 3:48:54 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,679
2,679
2,130
1,069
0
Operating Expense
211,259
211,259
265,591
229,025
165,323
Operating Income
-208,580
-208,580
-263,461
-227,956
-165,323
Net Non Operating Interest Income Expense
12,785
12,785
17,743
7,035
159
Other Income Expense
--
--
-20
-181
159
Pretax Income
-195,795
-195,795
-245,738
-221,102
-165,164
Tax Provision
0
0
678
0
0
Net Income Common Stockholders
-195,795
-195,795
-246,416
-221,102
-165,164
Diluted NI Available to Com Stockholders
-195,795
-195,795
-246,416
-221,102
-165,164
Basic EPS
-3.24
-3.24
-4.71
-5.32
-4.93
Diluted EPS
-3.24
-3.24
-4.71
-5.32
-4.93
Basic Average Shares
60,514.5460
60,514.5460
52,311.9580
41,543.9540
33,479.7820
Diluted Average Shares
60,514.5460
60,514.5460
52,311.9580
41,543.9540
33,479.7820
Total Operating Income as Reported
-208,580
-208,580
-263,461
-227,956
-165,323
Total Expenses
211,259
211,259
265,591
229,025
165,323
Net Income from Continuing & Discontinued Operation
-195,795
-195,795
-246,416
-221,102
-165,164
Normalized Income
-195,795
-195,795
-246,416
-221,102
-165,164
Interest Income
12,785
12,785
17,743
7,035
159
Net Interest Income
12,785
12,785
17,743
7,035
159
EBIT
-208,580
-208,580
-263,461
-227,956
-165,323
EBITDA
-199,468
-199,468
-255,184
-221,881
-160,839
Reconciled Depreciation
9,112
9,112
8,277
6,075
4,484
Net Income from Continuing Operation Net Minority Interest
-195,795
-195,795
-246,416
-221,102
-165,164
Normalized EBITDA
-199,468
-199,468
-255,184
-221,881
-160,839
Tax Rate for Calcs
0
0
0.0002
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/18/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6OP.F OSE Immunotherapeutics SA
5.83
-2.51%
HVE.F Innoviva, Inc.
16.60
+1.22%
SRZN Surrozen, Inc.
7.10
+3.65%
ABVX ABIVAX Société Anonyme
6.01
+0.33%
ORKA Oruka Therapeutics, Inc.
10.06
+6.34%
ZURA Zura Bio Limited
1.1100
-7.50%
KRON Kronos Bio, Inc.
0.6812
-3.38%
NXTC NextCure, Inc.
0.4380
+5.98%
INVA Innoviva, Inc.
18.58
+1.36%
FBRX Forte Biosciences, Inc.
7.85
+0.26%